Director/PDMR Shareholding

RNS Number : 4048C
GlaxoSmithKline PLC
15 April 2013
 



 

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 15 April 2013 of the following increases in their notional interests in Ordinary Shares and American Depositary Shares (ADSs) at a price of 1549.50 pence per Ordinary Share and $47.75 per ADS following the re-investment of dividends paid to shareholders on 11 April 2013.

 

 

Sir Andrew Witty

Acquisition of 1,224 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 1,224 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S Dingemans

Acquisition of 431 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 431 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S M Bicknell

Acquisition of 250 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 250 Ordinary Shares under the matching element of the Plan (Company contribution).



Mrs D P Connelly

Acquisition of 144 ADSs under the personal contribution element of the Plan.




Acquisition of 144 ADSs under the matching element of the Plan (Company contribution).



Mr W C Louv

Acquisition of 74 ADSs under the personal contribution element of the Plan.




Acquisition of 74 ADSs under the matching element of the Plan (Company contribution).



Mr D S Redfern

Acquisition of 301 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 301 Ordinary Shares under the matching element of the Plan (Company contribution).



Dr M M Slaoui

 

Acquisition of 588 ADSs under the personal contribution element of the Plan.




Acquisition of 588 ADSs under the matching element of the Plan (Company contribution).



Ms C Thomas 

Acquisition of 252 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 252 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr D E Troy

Acquisition of 301 ADSs under the personal contribution element of the Plan.




Acquisition of 301 ADSs under the matching element of the Plan (Company contribution).



Dr P J T Vallance

Acquisition of 547 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 547 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms E Walmsley

Acquisition of 156 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 156 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant three year measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

15 April' 2013

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQELFFXZFZBBV

Companies

GSK (GSK)
UK 100

Latest directors dealings